Notice: This company has been marked as potentially delisted and may not be actively trading. Zosano Pharma (ZSAN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Aktuelle Empfehlungen zur ZOSANOJuly 28, 2024 | finanznachrichten.deHOOK HOOKIPA Pharma Inc.April 12, 2024 | seekingalpha.comEast Bay Business NewsMay 18, 2023 | bizjournals.comAstellas PharmaApril 6, 2023 | forbes.comGiiant Pharma Receives Financial Support From the US Crohn’s and Colitis FoundationFebruary 5, 2023 | finance.yahoo.comZosano Pharma Corporation (ZSANQ)November 5, 2022 | ca.finance.yahoo.comBankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma GiantsOctober 12, 2022 | msn.comBankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of ClaimsAugust 28, 2022 | marketwatch.comEast Bay migraine patch developer Zosano closes sale in bankruptcy court for $1 millionAugust 27, 2022 | bizjournals.comZosano Pharma Corp (ZSANQ)August 25, 2022 | investing.comEast Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1MJuly 26, 2022 | bizjournals.comA Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.July 26, 2022 | bizjournals.comZosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSANJune 2, 2022 | marketwatch.comWhy Zosano Pharma Shares Are Getting Hammered TodayJune 2, 2022 | msn.comZosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%June 2, 2022 | seekingalpha.comCash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSANJune 2, 2022 | marketwatch.comEast Bay migraine patch developer files for bankruptcyJune 2, 2022 | bizjournals.comZosano Pharma Files Voluntary Petition for Relief Under Chapter 11June 2, 2022 | finance.yahoo.comTrading was temporarily halted for "ZSAN" at 07:06 AM with a stated reason of "News pending."June 2, 2022 | marketbeat.comEmergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle PatchMay 18, 2022 | apnews.comZosano Pharma Reports Q1 Net Loss of $33.4MMay 13, 2022 | investing.comZosano Pharma Reports First Quarter 2022 Financial ResultsMay 13, 2022 | finance.yahoo.comZosano Pharma Corporation (ZSAN) Outpaces Stock Market Gains: What You Should KnowMay 3, 2022 | finance.yahoo.comMigraine patch Zosano Pharma developer suspends program, cutting more jobsApril 29, 2022 | bizjournals.comMigraine patch developer Zosano Pharma suspends program, cutting more jobsApril 29, 2022 | finance.yahoo.comZosano Pharma suspends program for migraine treatment M207April 29, 2022 | seekingalpha.comZosano Pharma Provides Corporate UpdateApril 29, 2022 | finance.yahoo.comZosano Pharma slips as reverse stock split takes effectApril 12, 2022 | seekingalpha.comZosano Pharma Announces Reverse Stock Split Effective TodayApril 11, 2022 | finance.yahoo.comZosano Pharma (NASDAQ:ZSAN) Receives New Coverage from Analysts at StockNews.comStockNews.com initiated coverage on shares of Zosano Pharma in a report on Saturday. They set a "sell" rating for the company.March 26, 2022 | marketbeat.comLooking Into Zosano Pharma's Return On Capital EmployedMarch 18, 2022 | benzinga.comZosano Pharma (NASDAQ:ZSAN) Coverage Initiated at StockNews.comStockNews.com initiated coverage on Zosano Pharma in a report on Friday. They issued a "sell" rating for the company.March 18, 2022 | marketbeat.comZosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsMarch 17, 2022 | finance.yahoo.comZosano Pharma (NASDAQ:ZSAN) Downgraded by BTIG ResearchBTIG Research cut Zosano Pharma from a "buy" rating to a "neutral" rating in a research note on Wednesday.February 23, 2022 | marketbeat.comZosano Pharma plunges 48% on pricing $15.4M common stock and warrants offeringFebruary 9, 2022 | seekingalpha.comZosano Pharma Announces Publication Of Early Data On Influenza VaccineJanuary 5, 2022 | finance.yahoo.comZosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseJanuary 5, 2022 | finance.yahoo.comAiming to make Covid vaccines easier to take, East Bay company pushes forward with microneedle patchNovember 17, 2021 | finance.yahoo.comZosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch SystemNovember 17, 2021 | finance.yahoo.comZosano Pharma Reports Third Quarter 2021 Financial ResultsNovember 10, 2021 | finance.yahoo.comThinking about buying stock in Zosano Pharma, SoFi Technologies, Quantumscape, Nokia, or Hexo?November 1, 2021 | benzinga.comCSols Inc. Validates New LIMS at Zosano PharmaOctober 26, 2021 | businesswire.comZosano Pharma 8-K Shows Co. Refined Strategy For Resubmission Of M207 Microneedle System New Drug Application To FDAOctober 8, 2021 | benzinga.comZosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study ResultsOctober 4, 2021 | finance.yahoo.comZosano Pharma granted patent related to migraine treatment M207July 23, 2021 | seekingalpha.com Get Zosano Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZSAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover ZSAN Media Mentions By Week ZSAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZSAN News Sentiment▼0.000.54▲Average Medical News Sentiment ZSAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZSAN Articles This Week▼00▲ZSAN Articles Average Week Get Zosano Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZSAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMPE News Today EFTR News Today CLVR News Today LVTX News Today MYNZ News Today PHVS News Today PROC News Today BHVN News Today AMGN News Today LLY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZSAN) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zosano Pharma Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zosano Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZSAN Stock Alerts